Silver Spike Acquisition Corp II (SPKB) operates as a blank check company whose purpose is to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar initial business combination with one or more businesses. Formed in 2020 and headquartered at 660 Madison Avenue, Suite 1600, New York, New York, the company focuses on targets in the cannabis sector and alternative health and wellness industries that comply with applicable laws and regulations; it offers no independent products or services beyond pursuing and executing such business combinations. Sponsored by Silver Spike Sponsor II LLC, an affiliate of Silver Spike Capital, SPKB raised $250 million in its March 2021 initial public offering of 25 million units at $10.00 each on Nasdaq. In January 2022, the company announced a business combination agreement with Eleusis Holdings Ltd valued at $446 million to take the psychedelics developer public, which was mutually terminated in June 2022 due to unfavorable market conditions. Unable to complete a merger within the required 24-month period, SPKB announced in March 2023 the redemption of all outstanding Class A ordinary shares pro rata from its trust account and its intent to liquidate and dissolve, resulting in Nasdaq delisting and cessation of operations thereafter.